ArticleMolecular and clinical oncology2022

Neoadjuvant pertuzumab in non-metastatic HER2-positive breast tumors: Multicentric study in Peru (NeoHer).

Silvia Falcon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.